Close Menu

NEW YORK (GenomeWeb News) – Nanogen's shares began trading on the OTC Pink Sheets this morning after being removed from the Nasdaq market.

The transfer of the firm's common stock was expected after it announced a week and a half ago that it had received a delisting notice, which it did not intend to appeal.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.